Studies have shown that the expression of TLR2, TLR4, and their co-receptor cluster of differentiation 14 (CD14) is significantly upregulated in the intestinal mucosa of IBD patients, particularly in active UC and CD cases [8].This upregulation may lead to an excessive recognition of gut microbiota, triggering abnormal inflammatory responses. This evidence concerns the gene TLR2 and inflammatory bowel disease.